WINNERS & LOSERS: Shield Therapeutics down on Medicaid concerns
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More
| Price | 0.30p on 14-05-2026 at 16:30:01 |
|---|---|
| Change | 0.01p 3.45% |
| Buy | 0.32p |
| Sell | 0.28p |
| Last Trade: | Sell 2.00 at 0.28p |
| Day's Volume: | 4,062,360 |
| Last Close: | 0.30p |
| Open: | 0.295p |
| ISIN: | GB00BN7DVG54 |
| Day's Range | 0.295p - 0.30p |
| 52wk Range: | 0.1775p - 0.665p |
| Market Capitalisation: | £4.30m |
| VWAP: | 0.292139p |
| Shares in Issue: | 1.43b |
Sector: Media
Listed In: FTSE AIM All-Share,
Catenai Plc (CTAI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 2 | 0.28p | Ordinary |
16:29:31 - 14-May-26 |
| Sell* | 2 | 0.28p | Ordinary |
16:25:07 - 14-May-26 |
| Sell* | 437,710 | 0.2824p | Ordinary |
16:22:25 - 14-May-26 |
| Sell* | 34,222 | 0.281p | Ordinary |
16:22:10 - 14-May-26 |
| Sell* | 2 | 0.28p | Ordinary |
16:20:58 - 14-May-26 |
| Sell* | 2 | 0.28p | Ordinary |
16:16:03 - 14-May-26 |
| Sell* | 2 | 0.28p | Ordinary |
16:10:08 - 14-May-26 |
| Sell* | 2 | 0.28p | Ordinary |
16:01:05 - 14-May-26 |
| Sell* | 2 | 0.28p | Ordinary |
15:58:21 - 14-May-26 |
| Sell* | 2 | 0.28p | Ordinary |
15:55:47 - 14-May-26 |
Catenai Plc (CTAI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 20th Apr 2026 7:00 am | RNS | Contract Renewal and Klarian Update |
| 2nd Apr 2026 7:00 am | RNS-R | Alludium Achieves Certifications |
| 19th Mar 2026 7:00 am | RNS | Alludium secures first paying customers |
| 13th Mar 2026 7:30 am | RNS | Alludium Further Investment, Warrants & Update |
| 13th Mar 2026 7:30 am | RNS | Alludium Further Investment, Warrants & Update |
| 19th Feb 2026 7:00 am | RNS-R | Update re Alludium |
| 20th Jan 2026 7:00 am | RNS-R | New Company Website |
| 19th Jan 2026 12:32 pm | RNS | Holding(s) in Company |
| 5th Jan 2026 7:00 am | RNS | Klarian update |
| 19th Dec 2025 7:00 am | RNS-R | Further re Investor Presentation |